Trials / Completed
CompletedNCT00600288
Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)
A Multi-Center, Parallel-Group, Double-Masked, Randomized, Placebo-Controlled Study of the Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% and Placebo in Subjects With Dry Eye Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 261 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to evaluate the effect of diquafosol tetrasodium Ophthalmic Solution, 2% in dry eye subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | diquafosol tetrasodium Ophthalmic Solution, 2% | 1-2 drops administered in each eye 4 times a day for 6 weeks |
| DRUG | Non-preserved saline solution (Placebo) | 1-2 drops administered in each eye 4 times a day for 6 weeks |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2008-01-24
- Last updated
- 2015-01-09
Source: ClinicalTrials.gov record NCT00600288. Inclusion in this directory is not an endorsement.